{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:12:13Z","timestamp":1789827133728,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.maturitas.2017.06.021","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T07:00:35Z","timestamp":1497596435000},"page":"54-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Access to Anti-osteoporosis Medication after Hip Fracture in Korean Elderly Patients"],"prefix":"10.1016","volume":"103","author":[{"given":"Yun Mi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Yeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euni","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2017.06.021_bib0005","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.2009.50","article-title":"Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women","volume":"301","author":"Bliuc","year":"2009","journal-title":"JAMA J.AM. Med. Assoc."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025","volume":"22","author":"Burge","year":"2007","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrendo.2014.51","article-title":"Geographic and ethnic disparities in osteoporotic fractures","volume":"10","author":"Cauley","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0020","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s00198-016-3576-9","article-title":"Current trends and future projections of hip fracture in South Korea using nationwide claims data","volume":"27","author":"Ha","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0025","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"24","author":"Kanis","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0035","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.injury.2014.11.031","article-title":"The effect of osteoporotic treatment on the functional outcome, re-fracture rate, quality of life and mortality in patients with hip fractures: a prospective functional and clinical outcome study on 520 patients","volume":"46","author":"Makridis","year":"2015","journal-title":"Injury"},{"key":"10.1016\/j.maturitas.2017.06.021_bib0040","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2015.01.014","article-title":"Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study","volume":"128","author":"Kim","year":"2015","journal-title":"Am. J. Med."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0050","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00198-015-3415-4","article-title":"Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study","volume":"27","author":"Brozek","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0055","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jbmr.2202","article-title":"Osteoporosis medication use after hip fracture in U. S, patients between 2002 and 2011","volume":"29","author":"Solomon","year":"2014","journal-title":"J. Bone. Miner Res."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2458-10-230","article-title":"Incidence and mortality of hip fracture among the elderly population in South Korea: a population-based study using the national health insurance claims data","volume":"10","author":"Kang","year":"2010","journal-title":"BMC public health"},{"key":"10.1016\/j.maturitas.2017.06.021_bib0065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.maturitas.2014.11.001","article-title":"Gender inequalities in the treatment of osteoporosis","volume":"80","author":"Bor","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2017.06.021_bib0070","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic. Dis."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0075","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-016-3654-z","article-title":"Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses","author":"Zhou","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0080","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.maturitas.2013.11.002","article-title":"Effects of vitamin K in postmenopausal women: mini review","volume":"77","author":"Guralp","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2017.06.021_bib0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.amjopharm.2008.12.002","article-title":"Osteoporosis pharmacotherapy and counseling services in US ambulatory care clinics: opportunities for multidisciplinary interventions","volume":"6","author":"Teschemaker","year":"2008","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0090","series-title":"Change notification to reimbursement standards","author":"Ministry Health and Welfare","year":"2012"},{"key":"10.1016\/j.maturitas.2017.06.021_bib0095","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/092986710790416326","article-title":"Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions","volume":"17","author":"Corsonello","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0100","doi-asserted-by":"crossref","first-page":"a2752","DOI":"10.1136\/bmj.a2752","article-title":"Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study","volume":"338","author":"Zhang","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2017.06.021_bib0105","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/1756-0500-7-340","article-title":"Medical characteristics of the oldest old: retrospective chart review of patients aged 85+ in an academic primary care centre","volume":"7","author":"Tsoi","year":"2014","journal-title":"BMC Res notes"},{"key":"10.1016\/j.maturitas.2017.06.021_bib0110","doi-asserted-by":"crossref","first-page":"e1068","DOI":"10.3928\/01477447-20141124-53","article-title":"Medical management of fragility fractures of the distal radius","volume":"37","author":"Morgan","year":"2014","journal-title":"Orthopedics"},{"key":"10.1016\/j.maturitas.2017.06.021_bib0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.maturitas.2016.04.005","article-title":"Factors associated to institutionalization and mortality over three years, in elderly people with a hip fracture-An observational study","volume":"89","author":"Uriz-Otano","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2017.06.021_bib0120","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","article-title":"Meta-analysis: excess mortality after hip fracture among older women and men","volume":"152","author":"Haentjens","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0125","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/dc06-2606","article-title":"Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men","volume":"30","author":"Yaturu","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2017.06.021_bib0130","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00198-015-3123-0","article-title":"Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review","volume":"26","author":"Palermo","year":"2015","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0135","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1210\/jc.2005-2226","article-title":"Thiazolidinedione use and bone loss in older diabetic adults","volume":"91","author":"Schwartz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1503\/cmaj.080486","article-title":"Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis","volume":"180","author":"Loke","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.maturitas.2017.06.021_bib0145","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2017.06.021_bib0150","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1177\/1060028013509233","article-title":"Salmon calcitonin use and associated cancer risk","volume":"47","author":"Overman","year":"2013","journal-title":"Ann. Pharmacother."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512217300300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512217300300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:09:42Z","timestamp":1759914582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512217300300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":30,"alternative-id":["S0378512217300300"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2017.06.021","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Access to Anti-osteoporosis Medication after Hip Fracture in Korean Elderly Patients","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2017.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}